Waldencast plc - Class A Ordinary Share (NQ:WALD)

1.700 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	1.700
Bid (Size)	1.700 (100)
Ask (Size)	1.870 (200)
Prev. Close	1.700
Today's Range	1.700 - 1.700
52wk Range	1.450 - 4.100
Shares Outstanding	9,342,874
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

January 21, 2026

Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare

From Waldencast plc

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-0.6%	-0.6%
1 Month	-11.5%	-11.5%
3 Month	-8.6%	-8.6%
6 Month	-31.7%	-31.7%
1 Year	-43.9%	-43.9%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

November 24, 2025

From Waldencast plc

Via GlobeNewswire

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

November 16, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

November 14, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

November 12, 2025

From Waldencast plc

Via GlobeNewswire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

October 08, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

September 10, 2025

From Waldencast plc

Via GlobeNewswire

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

August 18, 2025

From Waldencast plc

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

August 18, 2025

Via Chartmill

Earnings Scheduled For August 18, 2025 ↗

August 18, 2025

Via Benzinga

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

August 18, 2025

Via Benzinga

Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast

July 23, 2025

Via ACCESS Newswire

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

July 23, 2025

From Waldencast plc

Via GlobeNewswire

Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 26, 2025

Via Benzinga

Waldencast Reports Q1 2025 Financial Results

May 13, 2025

From Waldencast plc.

Via GlobeNewswire

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

May 06, 2025

From Waldencast plc.

Via GlobeNewswire

Waldencast Q1 Preview: Beauty Brand Glow Dims On Soft Margins, Flat Sales ↗

May 06, 2025

Via Benzinga

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

April 22, 2025

From Waldencast plc.

Via GlobeNewswire

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

March 18, 2025

From Waldencast plc.

Via GlobeNewswire

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

March 11, 2025

From Waldencast plc.

Via GlobeNewswire

Waldencast Q4 Earnings Preview: All Eyes On Tariff Impact, Obagi Skincare Brand ↗

March 11, 2025

Via Benzinga

Frequently Asked Questions

Is Waldencast plc - Class A Ordinary Share publicly traded?

Yes, Waldencast plc - Class A Ordinary Share is publicly traded.

What exchange does Waldencast plc - Class A Ordinary Share trade on?

Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Waldencast plc - Class A Ordinary Share?

The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market

What is the current price of Waldencast plc - Class A Ordinary Share?

The current price of Waldencast plc - Class A Ordinary Share is 1.700

When was Waldencast plc - Class A Ordinary Share last traded?

The last trade of Waldencast plc - Class A Ordinary Share was at 01/21/26 04:00 PM ET

What is the market capitalization of Waldencast plc - Class A Ordinary Share?

The market capitalization of Waldencast plc - Class A Ordinary Share is 15.88M

How many shares of Waldencast plc - Class A Ordinary Share are outstanding?

Waldencast plc - Class A Ordinary Share has 16M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.